Skip to main content
. 2018 Jan 29;84(4):679–693. doi: 10.1111/bcp.13490

Table 1.

Summary of observational studies included

Description Levy et al., 2017 Jeong et al., 2012
Study design, population and duration Cross‐sectional study of 947 patients hospitalized in 12 departments of a tertiary academic medical Centre in Haifa, Israel from 2009 to 2014. A prospective study of 313 inpatients (87 male and 226 female) hospitalized in two Oriental Hospitals of Daejeon University, Daejeon, Korea from August 2008 to October 2010
Inclusion criteria Intake of herbal medicine at least 1 week prior to hospitalization.
Patients at 18 years and above who were able to communicate and provide verbal informed consent.
Intake of herbal medicine at least 10 days during hospitalization.
Exclusion criteria Not mentioned A life expectancy of <12 months (by judgment of the patient's doctor); current or previous liver diseases including carrier status of hepatitis virus, renal disease, or autoimmune disease; and abnormal baseline results on liver or renal function tests on hospitalization.
Sex Male: 152 (33%)
Female: 306 (67%)
Male 87 (27.8%)
Female 226 (72.2%)
Mean age 61.3 years 51 years
Herb users with different comorbidities 458 (100%) 313 (100%)
Metabolic 243 (53%)
Circulatory system 237 (52%) 87 (27.8%)
Haemato‐oncological 95 (21%) 77 (24.6%)
Musculoskeletal system 66 (21.1%)
Neurologic 38 (8%) 40 (12.8%)
Digestive system 39 (8.5%) 17 (5.4%)
Endocrine 132 (29%)
Respiratory 39 (8.5%)
Renal 37 (8%)
Rheumatological 37 (8%)
Pregnancy 30 (7%)
Psychiatric 29 (6%)
Ophthalmological 21 (5%)
Urological 17 (4%)
Hepatobiliary 10 (2%)
HIV 23 (7.3)
Others 3 (1.0)
Mode of causality assessment DIPS RUCAM score
Cases of ADR Total = 17
Herbs/pure compounds = 7
Other supplements = 10
Total = 6
Herb/pure compounds = 6
Other supplements = 0

ADRs classified by RUCAM score for liver injury; no provision of patient history and ADRs classified by Horn's DIPS score for other injuries. ADR = adverse drug reaction; HIV = human immunodeficiency virus; DIPS = drug interaction probability scale; RUCAM = Roussel Uclaf Causality Assessment Method